Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.5.1.5 (
urease
)
7,257
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
An all solid state potentiometric immunosensor (ASPI) has been developed to study the activation process of
neuronal nitric oxide synthase
(
nNOS
), the enzyme involved in the synthesis of nitric oxide generated under physiological conditions. At first, an all solid state H(+)-selective ISE was fabricated with the carboxylated poly(vinyl chloride) (PVC-COOH) film containing H(+) ionophore, antibody was then immobilized on the polymer layer. The immunocomplex formation was detected by monitoring pH change due to interaction between
urease
labeled secondary antibody and antigen. Experimental parameters such as the amount of phosphorylated
nNOS
immobilized on the electrode surface and pH responses due to the antibody-antigen reaction were studied in detail. The calibration plot of the potentiometric potential vs. phosphorylated
nNOS
concentration exhibited a linear relationship in the range of 3.4-340.0 microg/ml. The calibration sensitivity of the phosphorylated
nNOS
immunosensor was -0.073+/-0.002 mV/microg ml(-1). The detection limit of
nNOS
was determined to be 0.2 microg/ml based on five-time measurements (95% confidence level, k=3, n=5). The reliability of the immunosensor was examined with rat brain tissues as well as neuronal cells, and the results shown were good, implying a promising approach for a novel electrochemical immunosensor platform with potential applications to clinical diagnosis.
...
PMID:Monitoring the activation of neuronal nitric oxide synthase in brain tissue and cells with a potentiometric immunosensor. 1963 5